| Common Stock Reserved for Issuance |
The Company reserved the following shares of common stock for issuance:
|
|
|
|
|
|
|
|
|
September 30, 2025 |
|
|
December 31, 2024 |
|
Stock options outstanding |
|
12,580,264 |
|
|
|
9,711,075 |
|
Restricted stock units outstanding |
|
1,800,089 |
|
|
|
2,463,601 |
|
Shares reserved for future issuance |
|
5,134,310 |
|
|
|
4,295,342 |
|
Pre-Funded Warrant Shares |
|
— |
|
|
|
1,611,215 |
|
Apexigen replacement warrants |
|
1,003,191 |
|
|
|
1,003,191 |
|
Employee stock purchase plan |
|
653,777 |
|
|
|
573,316 |
|
Total |
|
21,171,631 |
|
|
|
19,657,740 |
|
|